342 related articles for article (PubMed ID: 19587505)
1. Stage of urinary bladder cancer at first presentation.
Al-Bazzaz PH
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):628-31. PubMed ID: 19587505
[TBL] [Abstract][Full Text] [Related]
2. Bladder cancer in Sri Lanka: experience from a tertiary referral center.
Goonewardena SA; De Silva WA; De Silva MV
Int J Urol; 2004 Nov; 11(11):969-72. PubMed ID: 15509199
[TBL] [Abstract][Full Text] [Related]
3. Overstaging of transitional cell carcinoma: clinical significance of lamina propria fat within the urinary bladder.
Bochner BH; Nichols PW; Skinner DG
Urology; 1995 Mar; 45(3):528-31. PubMed ID: 7879346
[TBL] [Abstract][Full Text] [Related]
4. [Can MRI be used to distinguish between superficial and invasive transitional cell bladder cancer?].
Tillou X; Grardel E; Fourmarier M; Bernasconi T; Demailly M; Hakami F; Saint F; Petit J
Prog Urol; 2008 Jul; 18(7):440-4. PubMed ID: 18602604
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion.
Andius P; Johansson SL; Holmäng S
Urology; 2007 Oct; 70(4):758-62. PubMed ID: 17991551
[TBL] [Abstract][Full Text] [Related]
6. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
Guney S; Guney N; Canogullari Z; Ergenekon E
Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479
[TBL] [Abstract][Full Text] [Related]
7. Voided urinary cytology in bladder cancer: is it time to review the indications?
Talwar R; Sinha T; Karan SC; Doddamani D; Sandhu A; Sethi GS; Srivastava A; Narang V; Agarwal A; Adhlakha N
Urology; 2007 Aug; 70(2):267-71. PubMed ID: 17826487
[TBL] [Abstract][Full Text] [Related]
8. Effect of vascular endothelial growth factor and its receptor inhibitor on proliferation and invasion in bladder cancer.
Nakanishi R; Oka N; Nakatsuji H; Koizumi T; Sakaki M; Takahashi M; Fukumori T; Kanayama HO
Urol Int; 2009; 83(1):98-106. PubMed ID: 19641368
[TBL] [Abstract][Full Text] [Related]
9. [Contribution of MRI in the staging of cancer of the bladder. Apropos of 40 cases].
Buy JN; Ghossain M; Guinet C; Richard F; Doucet M; Bigot JM; Vadrot D; Laval-Jeantet M; Ecoiffier J
J Radiol; 1989 Feb; 70(2):85-94. PubMed ID: 2654385
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.
Chen CH; Shun CT; Huang KH; Huang CY; Yu HJ; Pu YS
Urology; 2008 Jun; 71(6):1155-60. PubMed ID: 18372011
[TBL] [Abstract][Full Text] [Related]
11. [Nucleolar organizer region in bladder cancer. Relationship with histologic grade, stage, and prognosis].
Rivera P; Roa I
Actas Urol Esp; 1994 Mar; 18(3):204-6. PubMed ID: 8036947
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
[TBL] [Abstract][Full Text] [Related]
13. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
Isbarn H; Karakiewicz PI; Shariat SF; Capitanio U; Palapattu GS; Sagalowsky AI; Lotan Y; Schoenberg MP; Amiel GE; Lerner SP; Sonpavde G
J Urol; 2009 Aug; 182(2):459-65; discussion 465. PubMed ID: 19524971
[TBL] [Abstract][Full Text] [Related]
14. Use of Ulex europaeus agglutinin I (UEAI) to distinguish vascular and "pseudovascular" invasion in transitional cell carcinoma of bladder with lamina propria invasion.
Larsen MP; Steinberg GD; Brendler CB; Epstein JI
Mod Pathol; 1990 Jan; 3(1):83-8. PubMed ID: 2408038
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.
Jarmalaite S; Jankevicius F; Kurgonaite K; Suziedelis K; Mutanen P; Husgafvel-Pursiainen K
Oncology; 2008; 75(3-4):145-51. PubMed ID: 18824877
[TBL] [Abstract][Full Text] [Related]
16. Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors.
Palou J; Rodríguez-Rubio F; Millán F; Algaba F; Rodríguez-Faba O; Huguet J; Villavicencio H
Urology; 2009 Jun; 73(6):1313-7. PubMed ID: 19362341
[TBL] [Abstract][Full Text] [Related]
17. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
[TBL] [Abstract][Full Text] [Related]
18. Thymidine kinase 1: a proliferation marker for determining prognosis and monitoring the surgical outcome of primary bladder carcinoma patients.
Zhang J; Jia Q; Zou S; Zhang P; Zhang X; Skog S; Luo P; Zhang W; He Q
Oncol Rep; 2006 Feb; 15(2):455-61. PubMed ID: 16391869
[TBL] [Abstract][Full Text] [Related]
19. Activation of RAS family genes in urothelial carcinoma.
Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
[TBL] [Abstract][Full Text] [Related]
20. [The study of infiltrating lymphocytes in the tissues of bladder carcinoma].
Fujimoto Y; Hasegawa Y; Kato N; Sakai S; Kuriyama M; Kawada Y; Nishiura T; Takeuchi T; Isogai K
Hinyokika Kiyo; 1983 Sep; 29(9):1037-45. PubMed ID: 6610297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
